1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Lenus Therapeutics, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa RGN-137, Placebo - Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa | Phase 2 | Terminated | Lenus Therapeutics, LLC | 4 | 2019-05-22 | 2022-08-22 |
Epidermolysis Bullosa (1) · Epidermolysis Bullosa Dystrophica (1) · Epidermolysis Bullosa, Junctional (1)
United States (1)